Biosynthesis of Irumamycin: Understanding Its Complex Formation
Author Information
Author(s): Alferova Vera A., Baranova Anna A., Belozerova Olga A., Gulyak Evgeny L., Mikhaylov Andrey A., Solovev Yaroslav V., Zhitlov Mikhail Y., Sinichich Arseniy A., Tyurin Anton P., Trusova Ekaterina A., Beletsky Alexey V., Mardanov Andrey V., Ravin Nikolai V., Lapchinskaya Olda A., Korshun Vladimir A., Gabibov Alexander G., Terekhov Stanislav S., Simões Manuel
Primary Institution: 1 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia; 2 Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia; 3 Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russia; 4 Gause Institute of New Antibiotics, Moscow, Russia
Hypothesis
What are the mechanisms underlying the biosynthesis of Irumamycin?
Conclusion
The study reveals the biosynthetic pathways and mechanisms involved in the formation of Irumamycin, including the role of specific enzymes and structural features.
Supporting Evidence
- Irumamycin is produced by a type I polyketide synthase.
- The biosynthetic gene cluster for Irumamycin shows high similarity to that of venturicidin.
- Two potential pathways for hemiketal ring formation were proposed and assessed.
- Enzymes involved in epoxide formation specific to Irumamycin were identified.
- Activation energy calculations supported the proposed biosynthetic pathways.
Takeaway
Scientists studied how a special antibiotic called Irumamycin is made by tiny living things, discovering the steps and helpers involved in its creation.
Methodology
The study involved genomic analysis, enzyme characterization, and isotopic labeling experiments to investigate the biosynthetic gene cluster and mechanisms of Irumamycin production.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website